Amgen (AMGN) Stock Price vs Diluted EPS
Open the interactive overlay on autario.com.
In the year ending September 30, 2021, Amgen's diluted EPS declined 21.7% to $9.71 per share from $12.40 per share in the same quarter a year prior. Over that same period, the stock price fell 16.3%, from $254.16 to $212.65. Since the stock declined less steeply than earnings, the valuation multiple compressed relative to diluted EPS. As of the most recent price data on June 2, 2026, the stock traded at $326.42, representing a cumulative gain of 53.4% from the September 2021 quarter-end price, while diluted EPS over the intervening period remained below the 2019 peak of $13.03 per share.
Diluted EPS was $9.71/share as of 2021-09-30, -22% year over year. The stock moved -16% over the same window ($254.16 -> $212.65). Price and Diluted EPS moved almost in lockstep.
Latest close: 326.62 USD (2026-06-02).
Diluted EPS | recent SEC reports
| Report date | Diluted EPS | Period |
|---|
| 2021-09-30 | 9.71 USD/share | Q3 10-Q |
| 2021-06-30 | 9.83 USD/share | Q2 10-Q |
| 2021-03-31 | 12.07 USD/share | Q1 10-Q |
| 2020-12-31 | 12.31 USD/share | FY 10-K |
| 2020-09-30 | 12.40 USD/share | Q3 10-Q |
| 2020-06-30 | 12.24 USD/share | Q2 10-Q |
| 2020-03-31 | 12.76 USD/share | Q1 10-Q |
| 2019-12-31 | 12.87 USD/share | FY 10-K |
Sources: autario.com/data/stock-amgn-amgen-daily-prices · autario.com/data/amgen-diluted-eps-sec-filings | data verified and hosted on autario.com.